F railty-adjusted therapy i n T ransplant N on- E ligible patient s with newly diagno s ed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial (2022)

First Author: Coulson A
Attributed to:  TRAnsFORM: Trial Assessments of Fitness and Outcomes Research in Myeloma funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2021-056147

PubMed Identifier: 35654466

Publication URI: http://europepmc.org/abstract/MED/35654466

Type: Journal Article/Review

Parent Publication: BMJ Open

Issue: 6

ISSN: 2044-6055